SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Maaroufi, K.
Right arrow Articles by Bacha, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maaroufi, K.
Right arrow Articles by Bacha, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ochratoxin A in human blood in relation to nephropathy in Tunisia

K. Maaroufi

Laboratoire de Biochimie et de Toxicologie Moléculaire, Faculté de Médecine Dentaire, rue Avicenne, 5019 Monastir, Tunisia

A. Achour

Laboratoire de Biochimie et Service de Néphrologie, Faculté de Médecine et Centre Hospitalier Universitaire de Monastir, rue Avicenne, 5019 Monastir, Tunisia

M. Hammami

Laboratoire de Biochimie et Service de Néphrologie, Faculté de Médecine et Centre Hospitalier Universitaire de Monastir, rue Avicenne, 5019 Monastir, Tunisia

M. El May

Laboratoire de Biochimie et Service de Néphrologie, Faculté de Médecine et Centre Hospitalier Universitaire de Monastir, rue Avicenne, 5019 Monastir, Tunisia

AM Betbeder

Laboratoire de Toxicologie et d'Hygiène Appliquée, Unité de Formation et de Recherche des Sciences Pharmaceutiques, Université de Bordeaux 2, 3ter place de la Victoire, 33000 Bordeaux Cedex, France

F. Ellouz

Laboratoire de Biochimie et de Toxicologie Moléculaire, Faculté de Médecine Dentaire, rue Avicenne, 5019 Monastir, Tunisia

EE Creppy

Laboratoire de Toxicologie et d'Hygiène Appliquée, Unité de Formation et de Recherche des Sciences Pharmaceutiques, Université de Bordeaux 2, 3ter place de la Victoire, 33000 Bordeaux Cedex, France

H. Bacha

Laboratoire de Biochimie et de Toxicologie Moléculaire, Faculté de Médecine Dentaire, rue Avicenne, 5019 Monastir, Tunisia

The determination of ochratoxin A (OTA) in human blood in Tunisian populations is underway. The range of conta mination is between 0.7 to 7.8 ng ml-1 for the general popu lation and 12 to 55 ng ml-1 for people suffering from chron ic renal failure. It appears that 21 to 64% of people suffer ing from nephropathy are OTA positive with a detection limit of 1ng ml-1. This situation prompted us to search for possible association of OTA contamination and nephropa thy resembling Balkan endemic nephropathy. The classifi cation of the ill population into chronic interstitial nephropathy (CIN), chronic glomerular nephropathy (CGN), chronic vascular nephropathy (CVN) and others, indicated that the largest is the CIN group which is signifi cantly different from the other groups, and from the con trol (P < 0.005). Furthermore, it presented the highest OTA mean values (25 to 59 ng ml-1) compared with the control, CGN, CVN and other groups (6 to 18 ng ml-1) according to the designated region in Tunisia.

The rural population seems to be more exposed to ochratoxins in Tunisia, as has been previously reported in the Balkans and Western Europe.

Altogether, these results emphasise that in Tunisia an endemic ochratoxin-related nephropathy is probably occurring.

Key Words: ochratoxin A • human blood • nephropathy • Tunisia

Human & Experimental Toxicology, Vol. 14, No. 7, 609-614 (1995)
DOI: 10.1177/096032719501400710


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
H. Assaf, A.-M. Betbeder, E. E Creppy, M. Pallardy, and H. Azouri
Ochratoxin A levels in human plasma and foods in Lebanon
Human and Experimental Toxicology, October 1, 2004; 23(10): 495 - 501.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
W. Hassen, S. Abid-Essafi, A. Achour, N. Guezzah, A. Zakhama, F. Ellouz, E. E Creppy, and H. Bacha
Karyomegaly of tubular kidney cells in human chronic interstitial nephropathy in Tunisia: respective role of Ochratoxin a and possible genetic predisposition
Human and Experimental Toxicology, July 1, 2004; 23(7): 339 - 346.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
S. Abid, W. Hassen, A. Achour, H. Skhiri, K. Maaroufi, F. Ellouz, E. Creppy, and H. Bacha
Ochratoxin a and human chronic nephropathy in Tunisia: is the situation endemic?
Human and Experimental Toxicology, February 1, 2003; 22(2): 77 - 84.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
A Filali, A M Betbeder, I Baudrimont, A Benayada, R Soulaymani, and E E Creppy
Ochratoxin A in human plasma in Morocco: a preliminary survey
Human and Experimental Toxicology, May 1, 2002; 21(5): 241 - 245.
[Abstract] [PDF]


Home page
Toxicol SciHome page
E. O'Brien, A. H. Heussner, and D. R. Dietrich
Species-, Sex-, and Cell Type-Specific Effects of Ochratoxin A and B
Toxicol. Sci., October 1, 2001; 63(2): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
K Maaroufi, A Zakhama, I Baudrimont, A Achour, S Abid, F Ellouz, S Dhouib, E E Creppy, and H Bacha
Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats
Human and Experimental Toxicology, June 1, 1999; 18(6): 410 - 415.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Palli, M. Miraglia, C. Saieva, G. Masala, E. Cava, M. Colatosti, A. M. Corsi, A. Russo, and C. Brera
Serum Levels of Ochratoxin A in Healthy Adults in Tuscany: Correlation with Individual Characteristics and between Repeat Measurements
Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 265 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Sauvant, S. Silbernagl, and M. Gekle
Exposure to Ochratoxin A Impairs Organic Anion Transport in Proximal-Tubule-Derived Opossum Kidney Cells
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 13 - 20.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
E W Wafa, R S Yahya, M A Sobh, I Eraky, M El-Baz, H A. El-Gayar, A M Betbeder, and E E Creppy
Human ochratoxicosis and nephropathy in Egypt: A preliminary study
Human and Experimental Toxicology, February 1, 1998; 17(2): 124 - 129.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Schramek, D. Wilflingseder, V. Pollack, R. Freudinger, S. Mildenberger, and M. Gekle
Ochratoxin A-Induced Stimulation of Extracellular Signal-Regulated Kinases 1/2 is Associated with Madin-Darby Canine Kidney-C7 Cell Dedifferentiation
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1460 - 1468.
[Abstract] [Full Text]



Advertisement